192 related articles for article (PubMed ID: 28446521)
21. Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.
Kubica J; Adamski P; Buszko K; Kubica A; Kuliczkowski W; Fabiszak T; Jilma B; Alexopoulos D; Paciorek P; Navarese EP
Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):152-157. PubMed ID: 29040445
[TBL] [Abstract][Full Text] [Related]
22. Pre-hospital ticagrelor in ST-segment elevation myocardial infarction: Ready for prime time?
Alexopoulos D; Moulias A; Kanakakis I; Xanthopoulou I
Int J Cardiol; 2015 Sep; 194():41-3. PubMed ID: 26011263
[TBL] [Abstract][Full Text] [Related]
23. METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS-The METAMORPHOSIS Trial.
Sikora J; Niezgoda P; Barańska M; Buszko K; Skibińska N; Sroka W; Pstrągowski K; Siller-Matula J; Bernd J; Gorog D; Navarese EP; Marszałł MP; Kubica J
Thromb Haemost; 2018 Dec; 118(12):2126-2133. PubMed ID: 30453344
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics of ticagrelor and AR-C124910XX in patients with prior myocardial infarction
.
Röshammar D; Bergstrand M; Andersson T; Storey RF; Hamrén B
Int J Clin Pharmacol Ther; 2017 May; 55(5):416-424. PubMed ID: 28139972
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of fentanyl versus morphine on platelet inhibition induced by ticagrelor in patients with ST-segment elevation myocardial infarction: Full results of the PERSEUS randomized trial.
Iglesias JF; Valgimigli M; Carbone F; Lauriers N; Masci PG; Degrauwe S
Cardiol J; 2022; 29(4):591-600. PubMed ID: 35762079
[TBL] [Abstract][Full Text] [Related]
26. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function.
Teng R; Muldowney S; Zhao Y; Berg JK; Lu J; Khan ND
Eur J Clin Pharmacol; 2018 Sep; 74(9):1141-1148. PubMed ID: 29850937
[TBL] [Abstract][Full Text] [Related]
28. Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study.
Parodi G; Valenti R; Bellandi B; Migliorini A; Marcucci R; Comito V; Carrabba N; Santini A; Gensini GF; Abbate R; Antoniucci D
J Am Coll Cardiol; 2013 Apr; 61(15):1601-6. PubMed ID: 23500251
[TBL] [Abstract][Full Text] [Related]
29. Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose?
Guimarães PO; Tricoci P
Expert Opin Pharmacother; 2015; 16(13):1983-95. PubMed ID: 26224244
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics and pharmacodynamics of ticagrelor and AR-C124910XX in Chinese healthy male subjects.
Liu S; Xue L; Shi X; Sun Z; Zhu Z; Zhang X; Tian X
Eur J Clin Pharmacol; 2018 Jun; 74(6):745-754. PubMed ID: 29442148
[TBL] [Abstract][Full Text] [Related]
31. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
Venetsanos D; Sederholm Lawesson S; Alfredsson J; Janzon M; Cequier A; Chettibi M; Goodman SG; Van't Hof AW; Montalescot G; Swahn E
BMJ Open; 2017 Sep; 7(9):e015241. PubMed ID: 28939567
[TBL] [Abstract][Full Text] [Related]
32. Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibition in Acute Coronary Syndrome - the CHEERS study. For The PLATIS (Platelets and Thrombosis in Sheba) Study Group.
Asher E; Frydman S; Katz M; Regev E; Sabbag A; Mazin I; Abu-Much A; Kukuy A; Mazo A; Erez A; Berkovitch A; Narodistky M; Barbash I; Segev A; Beigel R; Matetzky S
Thromb Haemost; 2017 Apr; 117(4):727-733. PubMed ID: 28150850
[TBL] [Abstract][Full Text] [Related]
33. Contemporary use of P2Y
Rakowski T; Siudak Z; Dziewierz A; Plens K; Kleczyński P; Dudek D
J Thromb Thrombolysis; 2018 Jan; 45(1):151-157. PubMed ID: 29075924
[TBL] [Abstract][Full Text] [Related]
34. Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis.
Vercellino M; Sànchez FA; Boasi V; Perri D; Tacchi C; Secco GG; Cattunar S; Pistis G; Mascelli G
BMC Cardiovasc Disord; 2017 Apr; 17(1):97. PubMed ID: 28381298
[TBL] [Abstract][Full Text] [Related]
35. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study.
Silvain J; Storey RF; Cayla G; Esteve JB; Dillinger JG; Rousseau H; Tsatsaris A; Baradat C; Salhi N; Hamm CW; Lapostolle F; Lassen JF; Collet JP; Ten Berg JM; Van't Hof AW; Montalescot G
Thromb Haemost; 2016 Aug; 116(2):369-78. PubMed ID: 27196998
[TBL] [Abstract][Full Text] [Related]
36. Ticagrelor or prasugrel for pre-hospital protocols in STEMI?
Fournier N; Toesca R; Bessereau J; Champenois A; Mazille A; Luigi S; Yvorra S; Paganelli F; Brun PM; Michelet P; Meyran D; Auffray JP; Bonello L
Int J Cardiol; 2013 Oct; 168(4):4566-7. PubMed ID: 23871340
[No Abstract] [Full Text] [Related]
37. High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction.
Dillinger JG; Saeed A; Spagnoli V; Sollier CB; Sideris G; Silberman SM; Voicu S; Drouet L; Henry P
Thromb Res; 2016 Aug; 144():56-61. PubMed ID: 27289074
[TBL] [Abstract][Full Text] [Related]
38. The MOVEMENT Trial.
Holm M; Tornvall P; Henareh L; Jensen U; Golster N; Alström P; Santos-Pardo I; Witt N; Fedchenko N; Venetsanos D; Beck O; van der Linden J
J Am Heart Assoc; 2019 Jan; 8(2):e010152. PubMed ID: 30636504
[TBL] [Abstract][Full Text] [Related]
39. Lack of significant food effect on the pharmacokinetics of ticagrelor in healthy volunteers.
Teng R; Mitchell PD; Butler K
J Clin Pharm Ther; 2012 Aug; 37(4):464-8. PubMed ID: 21967645
[TBL] [Abstract][Full Text] [Related]
40. COMparison of Platelet reactivity following prAsugrel and ticagrelor loading dose in ST-Segment elevation myocardial infarctION patients: The COMPASSION study.
Laine M; Gaubert M; Frère C; Peyrol M; Thuny F; Yvorra S; Chelini V; Bultez B; Luigi S; Mokrani Z; Bessereau J; Toesca R; Champenois A; Dignat-George F; Paganelli F; Bonello L
Platelets; 2015; 26(6):570-2. PubMed ID: 25275609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
